share_log

Zentek Announces Closing of Non-Brokered Private Placement of Units

Zentek Announces Closing of Non-Brokered Private Placement of Units

Zentek宣布定向增发基金的结束
Zentek ·  2024/08/19 12:00

Guelph, ON – August 19, 2024, Zentek Ltd. ("Zentek" or the "Company") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company is pleased to announce that it has closed its non-brokered private placement of units (the "Units") through the issuance of 2,361,500 Units at a price of $1.30 per Unit (the "Offering") for gross proceeds of $3,069,950. Net proceeds of the Offering will be used for working capital and general corporate purposes.

安大略省盖尔夫——2024年8月19日,知识产权开发和商业化公司Zentek Ltd.(“Zentek” 或 “公司”)(纳斯达克股票代码:ZEN)欣然宣布,它已通过以每单位1.30美元的价格发行2,361,500套(“本次发行”),完成了非经纪单位私募配售(“单位”),总收益为每单位1.30美元(“本次发行”)为3,069,950美元。本次发行的净收益将用于营运资金和一般公司用途。

Zentek's CEO, Greg Fenton, commented: "We would like to thank all those who participated in the Offering. This funding will allow us to immediately allocate resources to our international market expansion strategy, where ZenGUARDTM-coated HVAC filters can play a meaningful role in an entity's sustainability objectives."

Zentek首席执行官格雷格·芬顿评论说:“我们要感谢所有参与此次发行的人。这笔资金将使我们能够立即为我们的国际市场扩张战略分配资源,在该战略中,ZenGuardtM涂层的HVAC过滤器可以在实体的可持续发展目标中发挥有意义的作用。”

Each Unit consists of one common share (each, a "Common Share") and one-half of one Common Share purchase warrant (each, a "Warrant"). Each whole Warrant entitles the holder thereof to purchase one Common Share at a price of $3.00 for a period of 24 months from the closing date of the Offering.

每个单位由一股普通股(每股均为 “普通股”)和一半的普通股购买权证(均为 “认股权证”)组成。每份完整认股权证的持有人有权在自发行截止之日起24个月内以3.00美元的价格购买一股普通股。

In connection with the closing of the Offering, the Company paid certain eligible persons a cash commission of $29,499.40 in the aggregate.

在本次发行结束时,公司向某些符合条件的人支付了总额为29,499.40美元的现金佣金。

Closing of the Offering remains subject to receipt of all necessary corporate and regulatory approvals, including the approval of TSX Venture Exchange. All securities issued in connection with the Offering are subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.

本次发行的结束仍需获得所有必要的公司和监管部门的批准,包括多伦多证券交易所风险交易所的批准。与本次发行有关的所有证券的持有期为四个月加一天,持有期自发行之日起,并受适用证券立法的转售规则约束。

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

本新闻稿不构成在美国出售任何证券的要约或招揽出售任何证券的要约。这些证券过去和将来都不会根据经修订的1933年《美国证券法》(“美国证券法”)或任何州证券法进行注册,除非根据美国《证券法》和适用的州证券法进行注册或获得此类注册豁免,否则不得在美国境内或向美国个人发行或出售。

About Zentek Ltd.

关于 Zentek Ltd.

Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.

Zentek是一家通过ISO 13485:2016 认证的知识产权技术公司,专注于新产品的研究、开发和商业化,旨在通过使公司的商业合作伙伴的产品更好、更安全、更环保,从而为其商业合作伙伴提供竞争优势。

Zentek's patented technology platform ZenGUARD, is shown to have 99-per-cent anti-microbial activity and to significantly increase the viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD production facility is located in Guelph, Ontario.

Zentek的专利技术平台ZenGuard被证明具有99%的抗微生物活性,可显著提高外科口罩的病毒过滤效率,其目标是对HVAC(供暖、通风和空调)系统起到同样的作用。Zentek 的 ZenGuard 生产设施位于安大略省圭尔夫。

For further information on Zentek:

有关 Zentek 的更多信息:

investorrelations@zentek.com
Ryan Shacklock
Senior VP, Strategy & Business Development
Email: rshacklock@zentek.com
Phone: 306-270-9610

investorrelations@zentek.com
Ryan Shacklock
战略与业务发展高级副总裁
电子邮件:rshacklock@zentek.com
电话:306-270-9610

To find out more about Zentek, please visit our website at . A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at .

要了解有关 Zentek 的更多信息,请访问我们的网站。本新闻稿和与公司有关的所有重要文件的副本可在Zentek的SEDAR+个人资料上获得,网址为。

Forward-Looking Statements

前瞻性陈述

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

本新闻稿包含前瞻性陈述。由于前瞻性陈述涉及未来的事件和状况,因此就其本质而言,它们涉及固有的风险和不确定性。尽管Zentek认为在本新闻稿中准备前瞻性信息时使用的假设和因素是合理的,但不应过度依赖此类信息,这些信息仅适用于本新闻稿发布之日,也无法保证此类事件会在披露的时间范围内或根本不会发生。除法律要求外,Zentek不打算或有义务更新或修改任何前瞻性信息,无论是由于新信息、未来事件还是其他原因。

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多伦多证券交易所风险投资交易所及其监管服务提供商(该术语在多伦多证券交易所风险投资交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发